Aurora Spine Corporation Grants Stock Options
January 19 2017 - 9:01AM
Aurora Spine Corporation ("Aurora Spine" or the "Company")
(TSXV:ASG) announces that it has granted options (the "Options") to
acquire 462,500 common shares of the Company to certain directors
of the Company. The Options are exercisable at a price of CDN$0.20
per common share and vest one third on the first, second and third
annual anniversaries from the date of grant. The Options have a
term of five years and are subject in all respects to the terms of
the Company's stock option plan.
The Option grants constitute a "related party
transaction" within the meaning of Multilateral Instrument 61-101 -
Protection of Minority Security Holders in Special Transactions
("MI 61-101") and the policies of the TSX Venture Exchange, but are
otherwise exempt from the formal valuation and minority approval
requirements of MI 61-101.
Neither the TSX Venture Exchange, nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange), accepts responsibility for
the adequacy or accuracy of this release.
About Aurora Spine
Aurora Spine is an early stage company focused
on bringing new solutions to the spinal implant market through a
series of screwless, innovative, minimally invasive, regenerative
spinal implant technologies. Aurora Spine continues to
position itself at the forefront of spinal surgery procedures,
focusing on minimally invasive spine surgery technologies.
Aurora Spine is changing spine surgery by focusing on disruptive
technologies following the Company’s commitment to – Simplifying
the Complex.
For additional information, or for a copy of the early warning report, please contact:
Aurora Spine Corporation
Trent Northcutt
President and Chief Executive Officer
(760) 424-2004
Eric Fronk
Chief Financial Officer
(760) 424-2004
www.aurora-spine.com
Aurora Spine (TSXV:ASG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Aurora Spine (TSXV:ASG)
Historical Stock Chart
From Apr 2023 to Apr 2024